Skip to main content
Caplight Logo









GenePlanet

GenePlanet

Private
LjubljanaHealthcare & Life Scienceshttps://geneplanet.com/

Last Round

Series B

Jul 13, 2023

Total Funding Raised

$22.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

GenePlanet is a biotechnology company that is a provider of innovative healthcare and lifestyle solutions based on preventive genetic testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS, Freemium

AI Layer

Application

Keywords

genetic testingat-home DNA testpreventative healthcarepersonalized healthbiotechnologydigital health platformwhole genome sequencingWGSnon-invasive prenatal testingNIPTprecision medicinecorporate wellnessinsurtech solutionspharmacogenomicscancer genetic screeninggenomic AImicrobiome test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenePlanet Comparables

Compare GenePlanet with similar companies based on industry and business-model similarity.

GenePlanet comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dante Labs
81%
LetsGetChecked
78%
Prenetics
76%

GenePlanet Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 13, 2023
VC RoundJul 9, 2018

Key People

Founding team and executive leadership

Marko Bitenc

Founder and CEO

Founding Team

GenePlanet Investors

Notable investors and investment history

GenePlanet investors
InvestorRounds
Designed Impact VenturesSeries B
BlackPeak CapitalSeries B
FMR d.o.o.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 4, 2026

    Open roles increased to 382, 2.2x the trailing average.

  • Jul 20, 2026

    Open roles increased to 377, 11.8x the trailing average.

GenePlanet Filings

Explore SEC and related filing metadata, where available.

GenePlanet filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GenePlanet's valuation, stock price, and market status.

Is GenePlanet a public or private company?

GenePlanet is a private company.

What is the current stock price of GenePlanet?

GenePlanet is a private company with no public stock price. No recent secondary market data is available.

How much is GenePlanet worth (valuation)?

Valuation information for GenePlanet is not publicly available.

Can I buy GenePlanet stock?

GenePlanet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GenePlanet's last funding round?

GenePlanet's most recent funding round was Series B on July 13, 2023.

Who are the main investors in GenePlanet?

Key investors in GenePlanet include BlackPeak Capital.

Will GenePlanet IPO soon?

No public IPO plans have been announced for GenePlanet.

How can I track GenePlanet secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenePlanet's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLjubljana
Employee Range126
Year Founded2008
Last FundingJul 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?